Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | GBA1 | P04062 | 4/20 | 0.54 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.52 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.52 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.52 |
| ▸ | GJB2 | P29033 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.44 |
| ▸ | TNF | P01375 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8370478 | 1.00 | MAPK1 (0.60) | MAPK1GBA1LGALS8LGALS3LGALS4 | |
| SCHEMBL546864 | 0.96 | MAPK1 (0.60) | MAPK1GBA1LGALS8LGALS3LGALS4 | |
| SCHEMBL25415432 | 0.93 | MAPK1 (0.60) | MAPK1GBA1LGALS8LGALS3LGALS4 | |
| SCHEMBL25414516 | 0.93 | MAPK1 (0.60) | MAPK1GBA1LGALS8LGALS3LGALS4 | |
| SCHEMBL25415166 | 0.93 | MAPK1 (0.60) | MAPK1GBA1LGALS8LGALS3LGALS4 | |
| SCHEMBL28276208 | 0.91 | MAPK1 (0.56) | MAPK1GBA1LGALS8LGALS3LGALS4 | |
| SCHEMBL28274960 | 0.91 | MAPK1 (0.56) | MAPK1GBA1LGALS8LGALS3LGALS4 | |
| SCHEMBL5678760 | 0.91 | MAPK1 (0.58) | MAPK1GBA1LGALS8LGALS3LGALS4 | |
| SCHEMBL21080979 | 0.89 | MAPK1 (0.54) | MAPK1GBA1LGALS8LGALS3LGALS4 | |
| SCHEMBL605059 | 0.86 | MAPK1 (0.67) | MAPK1GBA1LGALS8LGALS3LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1999052922-A1 | ANTIMICROBIAL βGalNAc(1→4)βGal DERIVATIVES AND METHODS OF USE | HELIX BIOPHARMA CORP. (CA) | 1999-10-21 | — | — | WO | disclosed |